{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T13:31:57Z","timestamp":1793367117018,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:00:00Z","timestamp":1788566400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["canadianjournalofophthalmology.ca","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Ophthalmology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jcjo.2026.09.002","type":"journal-article","created":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:42:34Z","timestamp":1793364154000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cataract surgery complications in individuals who previously received intravitreal injections"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-0789-3904","authenticated-orcid":false,"given":"Winnie W.","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marko M.","family":"Popovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6348-0895","authenticated-orcid":false,"given":"Ya-Ping","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev H.","family":"Muni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6006-7926","authenticated-orcid":false,"given":"Amandeep S.","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1376-845X","authenticated-orcid":false,"given":"David T.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Kertes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcjo.2026.09.002_bib0001","doi-asserted-by":"crossref","first-page":"e1221","DOI":"10.1016\/S2214-109X(17)30393-5","article-title":"Global causes of blindness and distance vision impairment 1990\u20132020: a systematic review and meta-analysis","volume":"5","author":"Flaxman","year":"2017","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.jcjo.2026.09.002_bib0002","doi-asserted-by":"crossref","first-page":"e144","DOI":"10.1016\/S2214-109X(20)30489-7","article-title":"Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study","volume":"9","author":"Bourne","year":"2021","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.jcjo.2026.09.002_bib0003","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/ICU.0000000000000850","article-title":"Complications of intravitreal injections: 2022","volume":"33","author":"Patel","year":"2022","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.jcjo.2026.09.002_bib0004","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/eye.2013.107","article-title":"Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature","volume":"27","author":"Falavarjani","year":"2013","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.jcjo.2026.09.002_bib0005","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/s41433-020-0806-3","article-title":"Global and regional prevalence of age-related cataract: a comprehensive systematic review and meta-analysis","volume":"34","author":"Hashemi","year":"2020","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.jcjo.2026.09.002_bib0006","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.ajo.2011.04.025","article-title":"Cataract surgery in ranibizumab-treated patients with neovascular age-related macular degeneration from the phase 3 ANCHOR and MARINA trials","volume":"152","author":"Rosenfeld","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jcjo.2026.09.002_bib0007","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jcrs.2011.10.036","article-title":"Outcomes of cataract surgery in patients with neovascular age-related macular degeneration in the era of anti-vascular endothelial growth factor therapy","volume":"38","author":"Tabandeh","year":"2012","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.jcjo.2026.09.002_bib0008","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/eye.2016.109","article-title":"Rate of intraoperative complications during cataract surgery following intravitreal injections","volume":"30","author":"Hahn","year":"2016","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.jcjo.2026.09.002_bib0009","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ajo.2017.02.006","article-title":"Risk of Posterior Capsule Rupture During Cataract Surgery in Eyes With Previous Intravitreal Injections","volume":"177","author":"Shalchi","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jcjo.2026.09.002_bib0010","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1136\/bjophthalmol-2020-318645","article-title":"Risk model for intraoperative complication during cataract surgery based on data from 900 000 eyes: previous intravitreal injection is a risk factor","volume":"106","author":"H\u00e5rd Af Segerstad","year":"2022","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jcjo.2026.09.002_bib0011","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/02713683.2020.1795884","article-title":"Posterior capsule rupture during cataract surgery in eyes receiving intravitreal anti-VEGF injections","volume":"46","author":"Miller","year":"2021","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.jcjo.2026.09.002_bib0012","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ophtha.2015.06.040","article-title":"Effect of prior anti-VEGF injections on the risk of retained lens fragments and endophthalmitis after cataract surgery in the elderly","volume":"123","author":"Hahn","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2026.09.002_bib0013","article-title":"ICES: data, discovery, better health","volume":"4","author":"Schull","year":"2019","journal-title":"Int J Popul Data Sci"},{"key":"10.1016\/j.jcjo.2026.09.002_bib0014","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/IJG.0000000000000369","article-title":"Double-organ bias in published randomized controlled trials of glaucoma","volume":"25","author":"Esen","year":"2016","journal-title":"J Glaucoma"},{"key":"10.1016\/j.jcjo.2026.09.002_bib0015","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4103\/ijo.IJO_928_22","article-title":"Vitreous hemorrhage\u2013causes, diagnosis, and management","volume":"71","author":"Shaikh","year":"2023","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.jcjo.2026.09.002_bib0016","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/ICU.0b013e3283524068","article-title":"Serious adverse events after cataract surgery","volume":"23","author":"Stein","year":"2012","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.jcjo.2026.09.002_bib0017","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/aos.15089","article-title":"Previous intravitreal injection as a risk factor of posterior capsule rupture in cataract surgery: a systematic review and meta-analysis","volume":"100","author":"Bjerager","year":"2022","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.jcjo.2026.09.002_bib0018","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.ophtha.2016.02.014","article-title":"Previous intravitreal therapy is associated with increased risk of posterior capsule rupture during cataract surgery","volume":"123","author":"Lee","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2026.09.002_bib0019","article-title":"Longitudinal follow-up of quiescent lens injury secondary to intravitreal antivascular endothelial growth factor injection","volume":"8","author":"Sun","year":"2020","journal-title":"J Cataract Refractive Surg Online Case Rep"},{"key":"10.1016\/j.jcjo.2026.09.002_bib0020","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ophtha.2011.08.011","article-title":"Effect on intraocular pressure in patients receiving unilateral intravitreal anti-vascular endothelial growth factor injections","volume":"119","author":"Hoang","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2026.09.002_bib0021","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.2147\/OPTH.S232548","article-title":"Incidence of glaucoma or ocular hypertension after repeated anti-vascular endothelial growth factor injections for macular degeneration","volume":"13","author":"Wingard","year":"2019","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jcjo.2026.09.002_bib0022","doi-asserted-by":"crossref","DOI":"10.1038\/srep39301","article-title":"Sustained elevation of intraocular pressure associated with intravitreal administration of anti-vascular endothelial growth factor: a systematic review and meta-analysis","volume":"6","author":"Zhou","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcjo.2026.09.002_bib0023","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1007\/s00417-019-04362-7","article-title":"Repeated intravitreal injections of antivascular endothelial growth factors and risk of intraocular pressure medication use","volume":"257","author":"Cui","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jcjo.2026.09.002_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100904","article-title":"Corneal endothelial dysfunction: Evolving understanding and treatment options","volume":"82","author":"Price","year":"2021","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.jcjo.2026.09.002_bib0025","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/ICO.0000000000001535","article-title":"Effects of repeated intravitreal aflibercept injection on the corneal endothelium in patients with age-related macular degeneration: outcomes From the RE-VIEW study","volume":"37","author":"Lass","year":"2018","journal-title":"Cornea"},{"key":"10.1016\/j.jcjo.2026.09.002_bib0026","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2147\/OPTH.S177506","article-title":"Effect of intravitreal aflibercept on corneal endothelial cells: a 6-month follow-up study","volume":"13","author":"Muto","year":"2019","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jcjo.2026.09.002_bib0027","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1017889","article-title":"Ocular adverse events associated with anti-VEGF therapy: a pharmacovigilance study of the FDA adverse event reporting system (FAERS)","volume":"13","author":"Ma","year":"2022","journal-title":"Front Pharmacol"}],"container-title":["Canadian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418226003649?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418226003649?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:42:38Z","timestamp":1793364158000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008418226003649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":27,"alternative-id":["S0008418226003649"],"URL":"https:\/\/doi.org\/10.1016\/j.jcjo.2026.09.002","relation":{},"ISSN":["0008-4182"],"issn-type":[{"value":"0008-4182","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cataract surgery complications in individuals who previously received intravitreal injections","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcjo.2026.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of Canadian Ophthalmological Society.","name":"copyright","label":"Copyright"}]}}